Discontinued — last reported Q3 '25
Equity
Common Stock
ResMed Common Stock remained flat by 0.0% to $763.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $761.00K to $763.00K. Over 4 years (FY 2021 to FY 2025), Common Stock shows an upward trend with a 6.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2025
How to read this metric
An increase indicates the issuance of new shares, which may dilute existing shareholders, while a stable balance indicates no new equity financing.
Detailed definition
This represents the aggregate par value of all common shares issued and outstanding. It is the foundational equity layer...
Peer comparison
Standard equity line item for all publicly traded companies.
Metric ID:
common_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $583.00K | $583.00K | $585.00K | $585.00K | $586.00K | $586.00K | $588.00K | $588.00K | $588.00K | $588.00K | $588.00K | $588.00K | $588.00K | $758.00K | $760.00K | $761.00K | $761.00K | $762.00K | $763.00K | $763.00K |
| QoQ Change | — | +0.0% | +0.3% | +0.0% | +0.2% | +0.0% | +0.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +28.9% | +0.3% | +0.1% | +0.0% | +0.1% | +0.1% | +0.0% |
| YoY Change | — | — | — | — | +0.5% | +0.5% | +0.5% | +0.5% | +0.3% | +0.3% | +0.0% | +0.0% | +0.0% | +28.9% | +29.3% | +29.4% | +29.4% | +0.5% | +0.4% | +0.3% |
Range$583.00K – $763.00K
CAGR+5.8%
Avg YoY Growth+7.6%
Median YoY Growth+0.5%
Current Streak19+ quarters growth
Common Stock at Other Companies
Frequently Asked Questions
- What is ResMed's common stock?
- ResMed (RMD) reported common stock of $763.00K in Q1 2026.
- How has ResMed's common stock changed year-over-year?
- ResMed's common stock increased by 0.3% year-over-year, from $761.00K to $763.00K.
- What is the long-term trend for ResMed's common stock?
- Over 4 years (2021 to 2025), ResMed's common stock has grown at a 6.9% compound annual growth rate (CAGR), from $583.00K to $761.00K.
- What does common stock mean?
- The total par value of all common shares issued to shareholders.